2014
DOI: 10.1016/j.brainres.2014.09.075
|View full text |Cite
|
Sign up to set email alerts
|

Neonatal dexamethasone accelerates spreading depression in the rat, and antioxidant vitamins counteract this effect

Abstract: The use of dexamethasone (Dex) to treat chronic lung disease in preterm infants may produce adverse effects in the developing brain. Here, we evaluated the effects of neonatal Dex on the propagation of cortical spreading depression (CSD), and tested the action of vitamins C and E against the effect of Dex. Five groups of Wistar rats received, respectively: [1] no treatment (Naïve); [2] Vehicle (V); [3] tapering doses of Dex (Dex; 0.5mg/kg, 0.3mg/kg, and 0.1mg/kg) on postnatal day (PND) 1-3; [4] Dex plus 200mg/… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
4
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 67 publications
2
4
0
Order By: Relevance
“…Prior studies have strongly suggested that GCs, which are major mediators of stress, are the major causal agent of MDD (52,53). Many studies have demonstrated that repeated administration of GCs can induce depressive-like behavior in rodents (54,55). In the present study, we showed that prenatal Dex exposure leads to continuous elevation of GC level in circulation even from E18.…”
Section: Discussionsupporting
confidence: 61%
“…Prior studies have strongly suggested that GCs, which are major mediators of stress, are the major causal agent of MDD (52,53). Many studies have demonstrated that repeated administration of GCs can induce depressive-like behavior in rodents (54,55). In the present study, we showed that prenatal Dex exposure leads to continuous elevation of GC level in circulation even from E18.…”
Section: Discussionsupporting
confidence: 61%
“…Furthermore, these data extend our knowledge about the actions of taurine and pilocarpine on electrophysiological responses and glial cell reactions, as demonstrated by the CSD-related potentiation of ECoG amplitude and microglial and astrocyte immunoreactivity. The previously described in vivo CSD-induced ECoG potentiation (Lopes-de-Morais et al, 2014;Mendes-da-Silva et al, 2018) has been confirmed in this paper, and its modulation by pilocarpine and taurine has been described (Table 1). Data on anxiety-like behavior, MDA measurements and brain immunohistochemical effects that were produced by taurine and/or pilocarpine treatment represent novel evidence of the action of these compounds on 35-55-day-old rats, whereas data on weight gain, glycemia, and CSD confirm the results of a previous study (Francisco and Guedes, 2018).…”
Section: Discussionsupporting
confidence: 85%
“…The ECoG and the DC (direct current) slow potential variation that is typical of CSD were continuously recorded on the cortical surface (on the intact dura mater) through a digital recording system (Biopac MP 150, Goleta, CA, United States). For each animal, the amplifier’s gain was kept constant over the entire recording session, as previously reported (Lopes-de-Morais et al, 2014).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Changes with cortical activity have been reported with perinatal dexamethasone. Tapered neonatal dexamethasone in rats alters cortical spreading depression velocity (an evoked propagating wave) in mature animals, but not cortical potentiation [83]. Whilst maternal exposure to dexamethasone in fetal sheep produces changes in EEG power bands lasting at least several days in utero [84], however it is unknown if these changes extend into adulthood, or for more than a few days.…”
Section: Discussionmentioning
confidence: 99%